Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Sanofi sign on office building Photo: Shutterstock.com

As the quest for a COVID-19 vaccine intensifies, companies at the forefront of research need to grapple with complex legal issues at all stages of the work, from the science of creating a safe and effective vaccine to the logistics of distribution and the management of risk. Karen Linehan, executive vice president of legal affairs and general counsel of Sanofi, the France-based pharmaceutical giant, took time out recently to discuss how her team gets involved in her company’s efforts to bring a COVID-19 vaccine to market.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.